Cereno Scientific participating at BIO 2024, June 3-6, San Diego
Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for rare and common cardiovascular disease, will participate at the BIO International 2024, taking place in San Diego, USA on June 3–6, 2024.Sten R. Sörensen, Chief Executive Officer (CEO) and Jeppe Øvlesen, Board member of Cereno, will attend the meeting and engage in partnering activities. "I look forward to meeting with pharmaceutical executives and potential investors to explore partnership and strategic opportunities for the Company’s portfolio of innovative treatments for rare and